Thomas M Polasek

18PUBLICATIONS
44CO-AUTHORS
Gene and molecular therapyPharmacogenomicsTheoretical quantum chemistryGene expression (incl. microarray and other genome-wide approaches)Medical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|May 07, 2026
A Review of Virtual Twins in Physiologically-Based Pharmacokinetic Modeling and Simulation.

|Jun 26, 2025
Using pharmacogenomics to personalise drug therapy: which drugs, when and how.

Sophie L Stocker, Thomas M Polasek

|Dec 10, 2024
Static Versus Dynamic Model Predictions of Competitive Inhibitory Metabolic Drug-Drug Interactions via Cytochromes P450: One Step Forward and Two Steps Backwards.

Ivan Tiryannik, Aki T Heikkinen, Iain Gardner

|Feb 08, 2024
Beyond Population-Level Targets for Drug Concentrations: Precision Dosing Needs Individual-Level Targets that Include Superior Biomarkers of Drug Responses.

Thomas M Polasek, Richard W Peck

|Jan 20, 2024
Virtual twins for model-informed precision dosing of clozapine in patients with treatment-resistant schizophrenia.

Sam Mostafa, Reza Rafizadeh, Thomas M Polasek

|May 19, 2023
The PRESIDE (PhaRmacogEnomicS In DEpression) Trial: a double-blind randomised controlled trial of pharmacogenomic-informed prescribing of antidepressants on depression outcomes in patients with major depressive disorder in primary care.

Sibel Saya, Patty Chondros, Anastasia Abela

Pageof 3

Frequent Collaborators

4 joint publications

Amin Rostami-Hodjegan

3 joint publications

Sam Mostafa

3 joint publications

Chad Bousman

3 joint publications

Carl Mj Kirkpatrick